You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AlloSCT

Showing 1 - 25 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influence of Timing PTCy in AlloSCT

Not yet recruiting
  • Cyclophosphamide Toxicity
  • Allogenic Haematopoetic Transplantation
  • (no location specified)
Jun 6, 2023

Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Advanced Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Chronic Lymphocytic Leukemia, Chronic Graft-versus-host-disease, Mantle Cell Lymphoma Trial in Poland (Acalabrutinib 2x100 MG

Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Acalabrutinib 2x100 MG Oral Capsule + alloSCT
  • Warszawa, Mazowieckie, Poland
  • +5 more
Dec 23, 2021

Acute Myeloid Leukemia Trial in Gainesville, Saint Louis, Rochester (drug, procedure, device)

Recruiting
  • Acute Myeloid Leukemia
  • Gainesville, Florida
  • +2 more
Aug 30, 2022

Epidermolysis Bullosa Trial in Aurora, Chicago, New York (Palifermin, Fludarabine, Busulfan)

Terminated
  • Epidermolysis Bullosa
  • Aurora, Colorado
  • +2 more
Aug 13, 2021

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Gemtuzumab Ozogamicin
  • Valhalla, New York
    New York Medical College
Nov 11, 2021

Sickle Cell Disease Trial in United States (Defibrotide)

Recruiting
  • Sickle Cell Disease
  • Los Angeles, California
  • +3 more
Mar 29, 2022

Patients at Risk for Chronic Graft-Versus-Host Disease

Not yet recruiting
  • cGVHD
  • Non-Interventional
  • (no location specified)
Jun 16, 2023

MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • IFN-γ (interferon gamma-1b) injection
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 5, 2023

Strategy for High-Risk Myelodysplastic Syndromes in Patients

Active, not recruiting
  • Myelodysplastic Syndromes
  • Allogeneic Stem Cell Transplantation
  • Agen, France
  • +9 more
Jul 5, 2022

B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Chronic

Terminated
  • B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
  • +16 more
  • Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 28, 2021

Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2 Trial in Melbourne (Venetoclax,

Recruiting
  • Leukemia, Myeloid, Acute
  • +5 more
  • Melbourne, Victoria, Australia
    Melbourne Health
Jun 19, 2022

Stem Cell Transplantation Trial in Basel (SMILe-Integrated Care Model, Usual Care)

Recruiting
  • Stem Cell Transplantation
  • SMILe-Integrated Care Model
  • Usual Care
  • Basel, Switzerland
    University Hospital Basel
Jan 27, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, NPM1 Mutation Trial in Bologna (Venetoclax+azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Bologna, Italy
    EMATOLOGIA- AOU Policlinico S.Orsola
Mar 1, 2022

Acute Lymphoblastic Leukemia Trial in Israel (Navitoclax, Venetoclax)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • Be'er Sheva, Israel
  • +5 more
Sep 14, 2021

Lymphoma Trial in Houston (Brentuximab Vedotin)

Terminated
Has Results
  • Lymphoma
  • Brentuximab Vedotin
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 15, 2019

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • New York, New York
    Columbia University Medical Center
Aug 4, 2021

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Gemtuzumab Ozogamicin
  • Valhalla, New York
    New York Medical College
Sep 26, 2022

Acute Myeloblastic Leukemia, Hematopoietic Stem Cell Transplantation Trial in Madrid (Passive music therapy)

Completed
  • Acute Myeloblastic Leukemia
  • Hematopoietic Stem Cell Transplantation
  • Passive music therapy
  • Madrid, Spain
    Instituto Investigacion Sanitaria Fundacion Jimenez Diaz
Jan 23, 2023

The Endothelial Cell Dysfunction and Outcome Project for

Not yet recruiting
  • Hematological Neoplasm
  • Endothelial Dysfunction
  • Sublingual in vivo microscopy with the Glycocheck microscope
  • (no location specified)
Aug 14, 2022

Classical Hodgkin Lymphoma, B-cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia Trial in Chicago (Pembrolizumab)

Recruiting
  • Classical Hodgkin Lymphoma
  • +3 more
  • Chicago, Illinois
    University of Chicago
Jun 29, 2021

Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

Not yet recruiting
  • Myeloid Malignancy
  • Acute Myeloid Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023

Acute Lymphoblastic Leukemia, Adult, Ph+ ALL, Newly Diagnosed Trial in Czechia (Ponatinib 15 MG Oral Tablet)

Active, not recruiting
  • Acute Lymphoblastic Leukemia, Adult
  • +2 more
  • Ponatinib 15 MG Oral Tablet
  • Brno, Czechia
  • +6 more
Nov 30, 2022

B-cell Acute Lymphoblastic Leukemia (B-ALL) Trial in Worldwide (AZD0486)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia (B-ALL)
  • Duarte, California
  • +30 more
Nov 13, 2023

Auto/Allo Tandem Transplant for Relapsed B-NHL

Completed
  • Non Hodgkin Lymphoma
  • auto transplant followed by allo transplant
  • (no location specified)
Oct 24, 2022